Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus

Hirotaka Ebina, Naoko Misawa, Yuka Kanemura, +1

Scientific Reports

Chromodomains direct integration of retrotransposons to heterochromatin

Xiang Gao, Yi Hou, Hirotaka Ebina, +2

Genome Research

Host genome surveillance for retrotransposons by transposon-derived proteins

Hugh P. Cam, Ken-ichi Noma, Hirotaka Ebina, +2

Nature

GeneticsGenome AnalysisGenome SequencingHost Genome SurveillanceGenomics +2

Characterization of RyDEN (C19orf66) as an Interferon-Stimulated Cellular Inhibitor against Dengue Virus Replication

Youichi Suzuki, Wei-Xin Chin, Qi’En Han, +17

PLoS Pathogens

Dengue Virus ReplicationViral ReplicationDengue VirusImmunologyMolecular Biology +18

Identification of Amino Acids in the Human Tetherin Transmembrane Domain Responsible for HIV-1 Vpu Interaction and Susceptibility

Tomoko Kobayashi, Hirotaka Ode, Takeshi Yoshida, +7

Journal of Virology

Anti‐HIV‐1 potency of the CRISPR/Cas9 system insufficient to fully inhibit viral replication

Shuhei Ueda, Hirotaka Ebina, Yuka Kanemura, +2

Microbiology and Immunology

Role of Nup98 in nuclear entry of human immunodeficiency virus type 1 cDNA

Hirotaka Ebina, Jun Aoki, Shunsuke Hatta, +2

Microbes and Infection

Natural SciencesHuman RetrovirusImmunologyDna ReplicationMolecular Biology +4

Quantitative Analysis of Human Immunodeficiency Virus Type 1 DNA Dynamics by Real-Time PCR: Integration Efficiency in Stimulated and Unstimulated Peripheral Blood Mononuclear Cells

Youichi Suzuki, Naoko Misawa, Chihiro Sato, +4

Virus Genes

Retrotransposon Tf1 Is Targeted to Pol II Promoters by Transcription Activators

Young-Eun Leem, Tracy L. Ripmaster, Felice D. Kelly, +6

Molecular Cell

Pol Ii PromotersTranscriptional RegulationProtein ExpressionNatural SciencesGenetics +7

A High Excision Potential of TALENs for Integrated DNA of HIV-Based Lentiviral Vector

Hirotaka Ebina, Yuka Kanemura, Naoko Misawa, +4

PLoS ONE

Dna-editing TechnologyViral ReplicationImmunologyMolecular BiologyHuman Immunodeficiency Virus +19